Skip to main content
Promino Nutritional Sciences Inc. logo

Promino Nutritional Sciences Inc. — Investor Relations & Filings

Ticker · MUSL ISIN · CA74290V2049 CSE Manufacturing
Open in API
Filings indexed 217 across all filing types
Latest filing 2024-06-04 Regulatory Filings
Country CA Canada
Listing CSE MUSL

About Promino Nutritional Sciences Inc.

https://drinkpromino.com/

Promino Nutritional Sciences Inc. is a research-driven nutraceutical company specializing in the development and distribution of science-based, clinically proven nutritional products for muscle health and recovery. The company focuses on patented formulations of essential amino acids (EAAs) designed to optimize muscle protein synthesis (MPS). Its flagship product, Promino™, is a consumer supplement that delivers a precise ratio and potency of all nine EAAs, demonstrated to be significantly more effective than traditional protein sources like whey. Promino's products target athletes and individuals seeking metabolic health improvements. The company also explores clinical applications, such as retaining muscle mass in cancer patients undergoing chemotherapy.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short form requesting shareholders to indicate if they want to receive Interim Financial Statements and/or Annual Financial Statements by mail. It does not contain any actual financial data or analysis, nor does it present the reports themselves. It is essentially a mailing list request form related to financial reports. Given the short length (1102 characters) and the nature of the content, this is not the report itself but a communication about distribution of reports. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement or communication that does not fit other categories.
2024-06-04 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a corporate update press release from Promino Nutritional Sciences Inc. It provides a summary of recent corporate developments including debt reduction, equity financing, re-establishment of intellectual property licenses, new product pre-clinical studies, athlete endorsements, and a proposed acquisition. The document does not contain detailed financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It also does not include earnings highlights typical of an Earnings Release (ER). The content focuses on corporate milestones, financing activities, and strategic updates, which aligns with a Capital/Financing Update (CAP). The document is over 10,000 characters, so it is not a brief announcement or report publication notice. Therefore, the best classification is Capital/Financing Update (CAP).
2024-06-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the commencement of preclinical studies by Promino Nutritional Sciences and Dr. Patrick Gunning. It discusses the company's research focus, product details, and forward-looking statements about the potential benefits of their nutritional supplements for cancer patients. There is no indication of financial data, regulatory filings, shareholder votes, or management changes. The content is promotional and informational about scientific research and company developments rather than a formal financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement or company news update that does not fit other specific categories, which corresponds to Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement of a report but a standalone news release.
2024-06-04 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing that Promino Nutritional Sciences will conduct preclinical trials evaluating the effectiveness of their product in conjunction with GLP-1 drugs for weight loss. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about upcoming research activities and product development, not a financial report, regulatory filing, or management discussion. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general corporate news announcement about research and development activities. Therefore, the best fitting category is Regulatory Filings (RNS) as a fallback for miscellaneous corporate announcements that do not fit other categories.
2024-06-04 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a commercial agreement between Promino Nutritional Sciences Inc. and the Las Vegas Lights FC soccer team. It contains promotional and marketing information about the partnership, product details, and forward-looking statements. There is no financial data, regulatory filing, report, or meeting-related content. It does not fit into any specific financial report or regulatory filing categories such as Annual Report, Earnings Release, or Management Reports. It is a general corporate announcement about a business partnership and brand promotion, which falls under the fallback category of Regulatory Filings (RNS).
2024-06-04 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a private placement financing by Promino Nutritional Sciences Inc. It details the terms of the offering, use of proceeds, and background information about the company and its products. There are no financial statements, regulatory filings, or detailed financial reports included. The content focuses on capital raising activities and financing terms, which aligns with the category for updates on company fundraising and capital structure changes. Therefore, the document fits best under the Capital/Financing Update (CAP) category.
2024-05-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.